Latest Breaking News On - Altius healthcare inc - Page 2 : comparemela.com

Devonian Bolsters Leadership Team and Aligns Strategy to Accelerate Clinical Development and Drive Revenue Growth and Commercial Success

04.12.2023 - Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, today . Seite 1

David bakerPierre montanaroAshish chabriaCompany boardAltius healthcare incCompany managementAltius healthcareChief scientific officerChief scientificDevonian health group chartEvonian health group kursEvonian health group aktie

Devonian Bolsters Leadership Team and Aligns Strategy to Accelerate Clinical Development and Drive R

Luc Grégoire, current Director of Devonian, appointed as President and CEO, brings 30 years of financial capital markets, strategic and operational leadershipDavid Baker transitions from board director with appointment as non-executive Chairman of the Board of DirectorsQUÉBEC CITY (BUSINESS WIRE) Devonian Health G.

David bakerAshish chabriaPierre montanaroRegulation services providerCompany boardDevonian health group incAltius healthcare incVenture exchange theNeither the exchangeCompany managementDevonian health groupAltius healthcareChief scientific officerChief scientificStock optionHealth group

Devonian Files Patent Cooperation Treaty (PCT) Application for Thykamine™ in Wound Healing

Devonian Files Patent Cooperation Treaty (PCT) Application for Thykamine™ in Wound Healing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Neither the exchangeCorporation tsxvVenture exchange theDevonian health group incAltius healthcare incRegulation services providerHealth groupPatent cooperation treatyGranulocyte colony stimulating factorGranulocyte macrophage colony stimulatingChief scientific officerDevonian health group

Devonian Announces Closing of a Private Placement of $500,000

Not for distribution to United States newswire services or for dissemination in the United StatesQUEBEC CITY (BUSINESS WIRE) Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of bot.

United statesPierrej montanaroAltius healthcare incCorporationa shareCorporation the unitsDevonian health groupRegulation services providerVenture exchangeNeither the exchangeDevonian health group incEach unitEach warrantHealth groupUnited states securities actChief executive officer

Devonian Announces Closing of a Private Placement of $1 2 Million

Not for distribution to United States newswire services or for dissemination in the United StatesQUEBEC CITY (BUSINESS WIRE) Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of bot.

United statesPierrej montanaroNone of the corporationDevonian health group incCorporation the unitsAltius healthcare incRegulation services providerVenture exchangeCorporationa shareNeither the exchangeDevonian health groupEach unitEach warrantFoot syndromeMinority security holdersSpecial transactions